| The role of MDR1 genetic polymorphisms in interindividual variability in P-glycoprotein expression and function EL Woodahl, RJY Ho Current drug metabolism 5 (1), 11-20, 2004 | 137 | 2004 |
| Stargazer: a software tool for calling star alleles from next-generation sequencing data using CYP2D6 as a model S Lee, MM Wheeler, K Patterson, S McGee, R Dalton, EL Woodahl, ... Genetics in Medicine 21 (2), 361-372, 2019 | 100 | 2019 |
| Multidrug resistance gene G1199A polymorphism alters efflux transport activity of P-glycoprotein EL Woodahl, Z Yang, T Bui, DD Shen, RJY Ho Journal of Pharmacology and Experimental Therapeutics 310 (3), 1199-1207, 2004 | 97 | 2004 |
| Multidrug resistance gene G1199A polymorphism alters efflux transport activity of P-glycoprotein EL Woodahl, Z Yang, T Bui, DD Shen, RJY Ho Journal of Pharmacology and Experimental Therapeutics 310 (3), 1199-1207, 2004 | 97 | 2004 |
| PharmVar GeneFocus: CYP2C19 MR Botton, M Whirl‐Carrillo, AL Del Tredici, K Sangkuhl, LH Cavallari, ... Clinical Pharmacology & Therapeutics 109 (2), 352-366, 2021 | 96 | 2021 |
| Pharmacogenetics in American Indian populations: analysis of: CYP2D6:: CYP3A4:: CYP3A5:, and: CYP2C9: in the Confederated Salish and Kootenai Tribes A Fohner, LAI Muzquiz, MA Austin, A Gaedigk, A Gordon, T Thornton, ... Pharmacogenetics and genomics 23 (8), 403-414, 2013 | 67 | 2013 |
| MDR1 G1199A polymorphism alters permeability of HIV protease inhibitors across P-glycoprotein-expressing epithelial cells EL Woodahl, Z Yang, T Bui, DD Shen, RJY Ho Aids 19 (15), 1617-1625, 2005 | 59 | 2005 |
| Ethical issues in developing pharmacogenetic research partnerships with American Indigenous communities BB Boyer, D Dillard, EL Woodahl, R Whitener, KE Thummel, W Burke Clinical Pharmacology & Therapeutics 89 (3), 343-345, 2011 | 53 | 2011 |
| Interrogation of CYP2D6 Structural Variant Alleles Improves the Correlation Between CYP2D6 Genotype and CYP2D6‐Mediated Metabolic Activity R Dalton, S Lee, KG Claw, B Prasad, BR Phillips, DD Shen, LH Wong, ... Clinical and translational science 13 (1), 147-156, 2020 | 49 | 2020 |
| PharmVar GeneFocus: CYP2C9 K Sangkuhl, K Claudio‐Campos, LH Cavallari, JAG Agundez, ... Clinical Pharmacology & Therapeutics 110 (3), 662-676, 2021 | 45 | 2021 |
| Gentamicin-induced ototoxicity and nephrotoxicity vary with circadian time of treatment and entail separate mechanisms MA Blunston, A Yonovitz, EL Woodahl, MH Smolensky Chronobiology international 32 (9), 1223-1232, 2015 | 45 | 2015 |
| MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents EL Woodahl, MH Crouthamel, T Bui, DD Shen, RJY Ho Cancer chemotherapy and pharmacology 64, 183-188, 2009 | 45 | 2009 |
| Pharmacogenetic research in partnership with American Indian and Alaska Native communities EL Woodahl, LJ Lesko, S Hopkins, RF Robinson, KE Thummel, W Burke Pharmacogenomics 15 (9), 1235-1241, 2014 | 44 | 2014 |
| Transfer learning enables prediction of CYP2D6 haplotype function G McInnes, R Dalton, K Sangkuhl, M Whirl-Carrillo, S Lee, PS Tsao, ... PLoS Computational Biology 16 (11), e1008399, 2020 | 39 | 2020 |
| Cytochrome P450 genetic variation associated with tamoxifen biotransformation in American Indian and Alaska native people BA Khan, R Robinson, AE Fohner, LAI Muzquiz, BD Schilling, JA Beans, ... Clinical and translational science 11 (3), 312-321, 2018 | 39 | 2018 |
| P450 Pharmacogenetics in Indigenous North American Populations LM Henderson, KG Claw, EL Woodahl, RF Robinson, BB Boyer, W Burke, ... Journal of personalized medicine 8 (1), 9, 2018 | 38 | 2018 |
| P-glycoprotein transport of neurotoxic pesticides SE Lacher, K Skagen, J Veit, R Dalton, EL Woodahl Journal of Pharmacology and Experimental Therapeutics 355 (1), 99-107, 2015 | 28 | 2015 |
| Pharmacogenomics in diverse practice settings: implementation beyond major metropolitan areas EH Dorfman, S Brown Trinidad, CT Morales, K Howlett, W Burke, ... Pharmacogenomics 16 (3), 227-237, 2015 | 28 | 2015 |
| Democratizing precision medicine through community engagement AE Fohner, KG Volk, EL Woodahl Clinical pharmacology and therapeutics 106 (3), 488, 2019 | 25 | 2019 |
| Absence of P-glycoprotein transport in the pharmacokinetics and toxicity of the herbicide paraquat SE Lacher, JN Gremaud, K Skagen, E Steed, R Dalton, KD Sugden, ... Journal of Pharmacology and Experimental Therapeutics 348 (2), 336-345, 2014 | 24 | 2014 |
